From the Guidelines
The Indian Association of Surgical Gastroenterology Conference (IASGCON) has been a pivotal event in shaping the field of surgical gastroenterology in India over the last decade, with a focus on evidence-based practice, technological innovations, and international collaboration, as seen in recent studies 1.
Overview of IASGCON
The conference has evolved significantly, featuring advancements in minimally invasive techniques, robotic surgery, and organ transplantation. Key topics include:
- Hepatobiliary surgery
- Colorectal procedures
- Gastrointestinal oncology Recent editions have emphasized evidence-based practice and incorporated technological innovations like artificial intelligence in surgical planning.
International Participation and Training
The conference has grown in international participation, with surgeons from across Asia and beyond attending to share expertise. IASGCON has also expanded its focus on training young surgeons through specialized sessions and simulation-based learning.
Conference Venues and Regional Participation
The conference venues have rotated among major Indian cities, including Delhi, Mumbai, Chennai, and Kolkata, allowing for regional participation and showcasing diverse surgical practices across the country.
Impact on Surgical Gastroenterology Practice
This annual event continues to be instrumental in shaping surgical gastroenterology practice in India through knowledge exchange and professional networking, with a focus on improving patient outcomes and reducing morbidity and mortality, as highlighted in studies on acute mesenteric ischemia 1.
Key Takeaways
- IASGCON has played a crucial role in advancing surgical gastroenterology in India
- The conference has emphasized evidence-based practice, technological innovations, and international collaboration
- Training young surgeons and regional participation are key aspects of the conference
- The event continues to shape surgical gastroenterology practice in India, with a focus on improving patient outcomes.
From the Research
IASGCON Overview
- IASGCON is not directly mentioned in the provided studies, however, the studies discuss proton pump inhibitors (PPIs) and their use in treating various gastrointestinal disorders.
- The studies examine the clinical pharmacology of PPIs, their similarities and differences, and their efficacy in treating conditions such as gastroesophageal reflux disease (GERD) and peptic ulcer disease 2, 3.
Proton Pump Inhibitors
- PPIs have emerged as the treatment of choice for acid-related diseases, including GERD and peptic ulcer disease 2.
- Comparative clinical trials have shown that PPIs administered once daily can produce endoscopic evidence of healing in >90% of patients with duodenal ulcer after 4 weeks of treatment, in >90% of those with gastric ulcer after 6 weeks of treatment, and in >90% of those with ulcerative or erosive GERD after 8 weeks of treatment 2.
- Maintenance therapy with daily doses of a PPI has been shown to be an effective means of preventing GERD relapse 2.
Recent Studies
- A 2022 study outlines the evidence surrounding appropriate PPI use for stress ulcer prophylaxis and peptic ulcer bleeding, highlighting the need for careful consideration of PPI use in hospitalized patients 4.
- A 2025 study examines the potential of natural products in the management of GERD, including their mechanisms of action and efficacy in preclinical and clinical studies 5.
- A 2023 systematic review compares the safety and efficacy of PPIs and histamine-2 receptor antagonists in the management of patients with peptic ulcer disease, highlighting the importance of considering the type and location of the ulcer and the potential for adverse effects 6.